Ameritas Investment Partners’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Ameritas Investment Partners’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,365	Closed	-$108K	–	3122
2021 Q3	$108K	Hold	5,365	–	–	﹤0.01%	1647
2021 Q2	$200K	Hold	5,365	–	–	0.01%	1252
2021 Q1	$137K	Sell	5,365 -374	-7%	-$9.55K	0.01%	1464
2020 Q4	$126K	Hold	5,739	–	–	0.01%	1435
2020 Q3	$103K	Hold	5,739	–	–	﹤0.01%	1408
2020 Q2	$146K	Buy	5,739 +1,289	+29%	+$27.8K	0.01%	1190
2020 Q1	$82K	Hold	4,450	–	–	﹤0.01%	1382
2019 Q4	$98K	Hold	4,450	–	–	﹤0.01%	1534
2019 Q3	$64K	Hold	4,450	–	–	﹤0.01%	1741
2019 Q2	$70K	Hold	4,450	–	–	﹤0.01%	1716
2019 Q1	$65K	Buy	4,450 +830	+23%	+$9.54K	﹤0.01%	1737
2018 Q4	$39K	Hold	3,620	–	–	﹤0.01%	1961
2018 Q3	$55K	Hold	3,620	–	–	﹤0.01%	1943
2018 Q2	$44K	Buy	+3,620	New	+$45.5K	﹤0.01%	2079

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Ameritas Investment Partners's DRNA Position: Q4 2021 in Review

Ameritas Investment Partners sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 5,365 shares — an estimated $108K sold.

Ameritas Investment Partners first reported a position in DRNA in Q2 2018 and held it in 14 quarters. The position peaked at $200K in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Ameritas Investment Partners reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Ameritas Investment Partners sold 5,365 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $108K.
Ameritas Investment Partners first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2018 and held it in 14 quarters.
Ameritas Investment Partners's Dicerna Pharmaceuticals, Inc. position peaked at $200K in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Ameritas Investment Partners's 13F filing for Q4 2021, filed 11 Feb 2022.